5 takeaways from STAT’s series on the soaring cost of health insurance
5 takeaways from STAT’s series on the soaring cost of health insurance (reported by STAT News)
News Archive
Browse all past biotechnology intelligence, clinical developments, and industry updates.
Archived Updates
AI care partner Heidi touts positive side effects in campaign
AI care partner Heidi touts positive side effects in campaign (reported by Fierce Pharma)
BMS details Krazati confirmatory fail in colorectal cancer
BMS details Krazati confirmatory fail in colorectal cancer (reported by Fierce Pharma)
BMS’ Krazati kneels to chemo in confirmatory colorectal cancer trial
BioSpace reports: BMS’ Krazati kneels to chemo in confirmatory colorectal cancer trial.
Caidya and Simbec-Orion unite in global CRO combo
Caidya and Simbec-Orion unite in global CRO combo (reported by Fierce Biotech)
Compass’ psilocybin depression drug works for the long haul
BioSpace reports: Compass’ psilocybin depression drug works for the long haul.
FDA Clears CliniComp PACS Viewer (MIMPS), Unifying Diagnostic Imaging, Enterprise EHR, and Native AI in a Single Platform
FDA Clears CliniComp PACS Viewer (MIMPS), Unifying Diagnostic Imaging, Enterprise EHR, and Native AI in a Single Platform (reported by PR Newswire)
Invictus Pharmacy and Mullan Pharmaceutical Inc. Announce Strategic Partnership to Expand Patient Access to FDA-Approved Ganirelix Acetate Injection Through Invictus Pharmacy
Invictus Pharmacy and Mullan Pharmaceutical Inc. Announce Strategic Partnership to Expand Patient Access to FDA-Approved Ganirelix Acetate Injection Through Invictus Pharmacy (reported by PR Newswire)
Medicine thinks Gen Z is too soft. It’s wrong
Medicine thinks Gen Z is too soft. It’s wrong (reported by STAT News)
MeiraGTx scores $400M to boost commercialization push
MeiraGTx scores $400M to boost commercialization push (reported by Fierce Biotech)
Novartis dismisses 322 more staffers based out of US headquarters
Novartis dismisses 322 more staffers based out of US headquarters (reported by Fierce Pharma)
Novartis, Vertex and Ipsen extend pharma's M&A spree after 45 first-half acquisitions
Novartis, Vertex, Ipsen and United Therapeutics kick off second-half M&A activity with up to $12.6B in new deals, extending a 45-deal run from 2026
Presage Technologies Earns FDA Clearance for Contactless Vital Signs, Makes Them Available for Free
Presage Technologies Earns FDA Clearance for Contactless Vital Signs, Makes Them Available for Free (reported by PR Newswire)
Saol Therapeutics Resubmits the New Drug Application for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD), an Ultra-Rare Disease
Saol Therapeutics Resubmits the New Drug Application for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD), an Ultra-Rare Disease (reported by PR Newswire)
Tanabe to sell manufacturing unit, rights to 17 meds to Towa
Tanabe to sell manufacturing unit, rights to 17 meds to Towa (reported by Fierce Pharma)